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INTRODUCTION
Solution-state NMR spectroscopy is used widely to determine the structures of peptides, proteins, and protein-ligand complexes, as well as those of nucleic acids and their complexes with proteins, drugs, and other molecules. As the field has developed, a certain consensus has evolved on the presentation of NMR solution structures. This has been helped indirectly by guidelines established for depositing primary experimental data and resulting structures in data banks such as the Protein Data Bank (ref. Structures (ref. 4) . In consideration of the accumulated experience over the past few years in presenting NMR structures, the time appeared to be appropriate for a formal examination of
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reporting conventions used in the past and for the development of a set of generally accepted guidelines for the future. With these goals in mind, the present Task Group was convened as an IUPAC/IUBMB/IUPAB Inter-Union venture with financial support from ICSU and CODATA. The present recommendations build upon earlier recommendations for biochemical nomenclature (ref. 5), the presentation of proton (ref. 6) and non-proton (ref. 7) NMR data for publication, and parameters and symbols for use in NMR (ref. 8).
1. Definition of the system studied
Names of the molecules used
It is helpful to use a notation that specifies the molecule type, natural species of origin, and fragment (if applicable): for example, "fragment consisting of residues 10-218 of murine Blk, a B-cell specific protein tyrosine kinase (PTC)." Note that recommendations for the naming of a variety of biological macromolecules have been published (ref. +14) .
Authors are encouraged to include identifiers used by publicly accessible databases (ref. 15) , as these may be helpful for cross-referencing purposes. Such identifiers include the accession codes used by the Protein Identification Resource (ref. 16) , , the Enzyme Commission of IUBMB (ref. 18) , and the Chemical Abstracts Service (ref. 19).
Source

0
Genus, species, strain or variant of gene (cloned or synthetic). Expression vector and host. If chemically synthesized, a description of the methods used.
Evidence for homogeneity and chemical identity
Confrmation of chemical identity (e.g., from mass spectrometry or chemical sequencing). Analytical method used to establish chemical homogeneity.
Sequence or chemical structure
Full sequence of the molecule (or reference to it). Unambiguous definition of the sequence numeration of the molecule studied. Description of additional covalent linkages and their locations: e.g., disulfide bridges, covalently attached cofactors, or metal ions. Description of any differences between the system studied and the naturally-occurring biomolecule (e.g., fragment with additional or fewer residues at either end of the biopolymer, post-transcriptional modifications in nucleic acids or post-translational modifications in proteins, or lack thereof). Specification of noncovalent cofactors or prosthetic groups. Quaternary structure (number and kind of subunits; symmetry, if known).
Solution conditions
Specification of the solvent constituents and their isotopic compositions. Concentration of each solute component, including buffers, salts, antibacterial agents, etc. Temperature and pressure along with methods used for their measurement. Value of the pH, or pH* for uncorrected pH meter readings in 2H20. Note that p2H (or "pD') applies only to measurements made with electrodes filled with 2H20. Comment on special measures taken to minimize self-aggregation (if applicable). Type of sample cell used.
Isotope-labeled proteins and nucleic acids
Essential information would include descriptions of the methods used to prepare the labeled molecules and to determine the positions and levels of isotopic labeling in the system used. Percent incorporation should be indicated when known, as illustrated in the following examples. 
Atom identifiers for reporting chemical shift assignments
The 1983 IUPAC-IUB recommendations for peptides and proteins (ref. 21) were never widely adopted by the protein science community. Thus the present recommendations for peptides and proteins follow the earlier IUPAC-IUB "tentative rules " of 1969 (ref. 20) currently employed by biomolecular databases, with extensions and clarifications as required for NMR data. These rules designate all atoms by Greek letters (or Roman counterparts) and employ the main chain precedence rule for numbering prochiral sites. The present recommendations for nucleic acids follow the IUPAC-IUB nomenclature (ref. 22) , with three exceptions. First, notation for the hydrogens at the C5' position in ribose and deoxyribose follows the widespread use of H5' (for pro-S) and H5" (for pro-R), rather than H5'1 and H5'2 (the latter notation (ref. 22 ) is inconsistent with the numbering convention used with amino acids, in which such atoms would be designated as 2 and 3). Second, H2' (for pro-S) and H2" (for pro-R) are used to designate the hydrogens at the C2'-position in deoxyribose. Third, the notation proposed for hydroxyl groups of ribose and deoxyribose rings in reference 22 is adapted from that used with amino acids, so that the hydrogen atoms are denoted by HO2', Ho3', and HO5', as appropriate, whereas the hydroxyl oxygens are denoted by 05', etc.
In cases not covered by the present recommendations (e.g., unusual or modified amino acid residues or nucleic acid bases), authors are encouraged to refer to notation in use by the databases for such groups. If new atom notation needs to be introduced, it will be helpful if authors define this by providing stereospecific diagrams as appropriate. Figure 1 defines the atom-naming conventions recommended here for proteins. Coordinate files should contain all atoms, including hydrogen atoms. The 1969 recommendations (ref. 20) did not deal explicitly with nomenclature for hydrogen atoms, and the rules are subject to different interpretations. The interpretation recommended here ( Fig. 1 ) is that at any position of the side chain, the attached atom leading to the main chain always has the highest priority. For cyclic amino acids such as proline, the priority leads out from the main chain Ca atom rather than from the N atom (i.e., the priority is given by C a > CP > CY > ... > N). In the peptide backbone, the nitrogen is denoted by N, its attached hydrogen by H, and the carbonyl carbon and oxygen by C and 0, respectively (ref. 20) . In cases where the single letter designations are ambiguous, they may be primed (e.g., N', C', 0') (ref. 20); C' is used quite widely to denote the peptide backbone carbonyl carbon. Although H alone is used by the biomolecular data banks (PDB and BMRB), it is recommended here that the symbol HN (in widespread use in the NMR community) be used as the unambiguous designator for the backbone amide hydrogen. The hydrogens of an N-terminal amine are designated as H1, H2, and H3 (when protonated) or H1 and H2 (when unprotonated). The oxygens of a C-terminal carboxyl or carboxylate are 0' and 0", and the hydrogen of the carboxyl is H". IUPAC rules (ref. 18) label the hydrogens on methyl groups and protonated amines by "l", "2", and "3", in the conventional way.
Proteins and peptides
Standard nomenclature
Thus, for example, the atom designations in amino acid side chains would be: Hpl, HE, and H B for the three methyl hydrogens $f alanine; HC', HO, and HD for the three amine hydrogens of a protonated lysine; and HCl and HO for the two amine hydrogens of a neutral lysine. 
Other stereochemical ambiguity
When flips of the symmetrical ring of a phenylalanine or tyrosine are slow on the chemical shift time scale, signals from the 6-and &-atoms can have non-equivalent shifts. In such cases, information about assignments relative to the x2 torsion angle is needed to define the specific atom designators 1 and 2. This information often is not known in advance of a full structure determination, so it is useful to specify this level of ambiguity again with the slash rule. For example, if proton signals at 6. 60, 6.95, 7.12, and 7.22 All pseudoatoms needed to describe proteins and nucleic acids can be specified in terms of two letters, Q and M, in conjunction with the usual atom identifiers (Roman letters are used instead of Greek letters for atom positions within amino acids, and R is used to denote a ring). M describes the location of methyl groups, and Q is used in all other situations. Table 1 lists all pseudoatoms in the common amino acids and nucleotides. symmetry-related protons which have non-degenerate chemical shifts and have not been assigned individually, can be distinguished unambiguously on the basis of the chemical shifts. For example, an NOE observed at 3.12 ppm to one of a pair of methylene proton resonances at 2.44 ppm and 3.12 ppm, which were assigned ambiguously to the HBID atoms of Tyr57 is reported as an NOE to Tyr57 HBlD (3.12 Ppm). Alternatively, the symbols "L" and "H" can be used to represent the resonances at lower frequency (historically referred to as "downfield") and higher frequency (historically "upfield"), respectively. In the above example, the NOE would then be to Tyr57 H k .
NOE constraints that can be identified by chemical shifts
p-D-ribose 2'-p-D-deoxyribose A C G T a-methylene p-met hyl 71-, @-methyl all six ymethyl $2-, &-methyl 71 -methylene 61-, &-methyl p-methylene all six &methyl p-, y , gmethylene Pmethylene @-methyl p-met hylene p-, ymethylene p-, ymethylene &2-amido p-, y, 6 , emethylene
Nomenclature for specifying conformation
Torsion angles are defined in terms of the substituent with highest preference on each of the two atoms that span the rotatable bond (ref. 20, 35) . The IUPAC-IUB convention (ref. 20, 22) specifies that the main chain atoms of a peptide or nucleic acid take precedence over others. For example, in a peptide, the backbone carbon and nitrogen atoms take precedence over other heavier atoms such as the carbonyl oxygen or cysteine CP ( of thefront bond that would be required to achieve the eclipsed conformation is clockwise, B is considered to be positive; if the required minimal rotation is counter-clockwise, 8 is considered to be negative. As defined below, various abbreviations are used to denote specific torsion angles in proteins and nucleic acids; in other situations (or to avoid any ambiguity) the four atoms that determine the torsion angle should be specified.
Polypeptides
Backbone torsion angles: 4 i, wit and mi
The @i torsion angle describes rotations about the Ni-Cni bond (relevant four atoms 
Specification of turns, disulfide bonds, and proline rings
Turns can be defmed unambiguously by the torsion angles involved, i.e., @i+l, @i+2, and t+q+2 (ref. 36 (Fig. 4) . and glycosidic (2) torsion angles for purine 
Nucleic acids
HP3 Hy3 DOWN UP 0 3 ' j . r PI-05'1-C5'j PI-05'1-C5' 1-C4'j 05'1-C5'1-C4' l -C3'j C5' 1-C4' l -C3' 1-03'j C4' 1-C3' l -03'1-Pi+, C3' l -03'1-Pi+-05'j+1 04'l-C1'l-N11-C2i 04'i-C 1' 1-N91-C4jVO ~1 C4' -04'-C 1' -C2' 04'-C 1' -C2' -C3' v, C1' -C2' -C3' -C4' ~3 C2' -C3' -C4' -04' ~4 C3' -C4' -04'-C1' base XI %/ C"\", 04
C2'
Note that v3 and 6, which characterize torsion angles
about the Same bond (C3'-C4'), wfl have different
values for any given conformation.
The sugar is generally non-planar, and it is recommended that the sugar ring conformation (pucker) be described by specifying two parameters: the phase angle of pseudorotation ( P ) and the puckering am- Fig. 5 . Designation of the torsion angles in the sugarplitude vm. In practice, the pseudorotation pa-phosphate backbone (a, P, ?, 6, E, i), the glycosidic bond (x), rameters can be determined from measurements of and the endocyclic torsion angles in the sugar ring ( V O -v4) the three-bond J-couplings between the protons attached to Cl', C2', C3', and C4'. The following equations characterize relationships among the torsion angles defmed by these protons and the pseudorotation parameters (ref. (7') conformations are found at even multiples of 18" and that the symmetrical envelope conformations are found at odd multiples of 18".
In these equations the non-equilateral character of the sugar ring is accounted for. The qVs can be derived from the &ouplings by means of appropriate Karplus equations.
Relationships among the phase angle of pseudorotation and the alternative EIT and endo/exo notations are illustrated by the pseudorotation wheel in Fig. 6 . In the EIT nomenclature, the puckered forms are designated by E (envelope form) and T (twist form) (ref. 22) . For example, P = +18" is equivalent to C3'-endo or 3 E , and P = -162" is equivalent to C3'-exo or E . Symmetrical twist conformations, with two atoms at equal distance with respect to the plane defined by the three remaining ring atoms, can also be represented; for example, P = 0" is equivalent to C3'-endo/C2'-exo, or to i T .
Value ranges for torsion angles specifying commonly observed conformations
In practice, torsion angles are often not known exactly, but can be assigned to particular conformational regions. The notation used most frequently by spectroscopists and X-ray crystallographers for ranges of torsion angles is cis , trans, -gauche, and +gauche as shown in Fig. 7 . The IUPAC-IUB Commission on Nucleotide Nomenclature recommended the
, and f antiperiplanar (f up) as defined in Fig. 7 . The terms syn (Oak 90') and anti (180" * 90') have special meanings in nucleotide chemistry in that they are used to define the orientation of the base with respect to the sugar. Table 2 lists the predominant conformations of nucleic acids and the associated ranges of torsion angles. (Fig. 7) . Several torsion angles in standard polynucleotide conformations fall outside the ranges defined by these symbols. This information is also given in the table in that angle values outside the range by less than 10' are enclosed by brackets and those outside the range by more than 10' are enclosed by double brackets. In these cases, the Klyne-Prelog notation provides a more accurate representation of the torsion angle range. bGuanine residue in Z-DNA. CCytosine residue in Z-DNA.
NMR data acquisition, processing, and referencing
This section gives recommendations on how to present information needed to provide a comprehensive description of the experiments used in a structure determination.
Data acquisition
The following information describes the data collection process. In particular, a complete account is needed for experiments employed in the collection of conformational constraints.
0
NMR hardware used. Customarily the magnetic field is specified by the resonance frequency of a particular nucleus, usually 'H; other minimal information includes the type of console, type of probe head and the size and nature of the sample tubekontainer. Additional details might be desirable for the description of novel experimental protocols or home-built systems.
Protocols for the acquisition of raw data. This normally includes a diagram of the pulse sequence and/or an ASCII fde with the code for the pulse program, or a reference if previously published routines were used. It is important to include information on details of solvent suppression, timing parameters, r.f. power levels (or equivalent 90' pulse duration), phase cycling, pulse shapes, any magnetic field gradients (magnitudes and durations), the modes of acquisition for each dimension (including method for quadrature detection), the recycle delay, and the total time required for data acquisition. Description of time domain data. This usually includes acquisition times, spectral widths, possible use of non-linear sampling, and the number of real or complex data points in each time domain.
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Data processing
A comprehensive description of data processing normally includes the following information: Software packages used. Enhancement of the time-domain data. This may include digital filtering, solvent filtering, convolution with a window function, zero filling, or linear prediction. Time-domain to frequency-domain conversion. The Fourier transform is the most common method, but alternatives may be employed, such as maximum entropy, maximum likelihood, or Bayesian analysis. The final data size and digital resolution in each dimension are part of a complete documentation. Enhancement of frequency-domain data. Common methods include symmetrization, baseline flattening, and ridge or solvent suppression. Methods used to extract spectral parameters such as resonance frequencies, peak volumes, and coupling constants.
Referencing of chemical shifts
According to general convention, NMR spectra are displayed with positive frequencies to the left and negative frequencies to the right of the zero-frequency reference (ref. 
'H chemical shifts
The methyl resonance of internal DSS at low concentration directly provides the preferred reference signal for 0 ppm: notation, S , , , or G(DSS).
Chemical shifts of other nuclei such as 2H, l3C, 15N, and 31P.
a number Of direct and indiapproaches have been described for the referencing of chemical shifts of nuclei other than 'H, the indirect referencing method (ref. 44) has become the preferred approach. Nonproton chemical shifts are referenced indirectly to the 'H standard using conversion factors derived from raThe relative frequencies are designated by the symbol E, with l H conventionally at exactly 100 MHz. E values for the nuclei most commonly util- 13C chemical shifts is obtained from the experimentally determined lH frequency for DSS by multiplying the latter frequency by the "C/lH Eratio, 25.1449530 /100.000000 = 0.251449530. In order to tie in with the chemical shift scales used in much of the previous literature, these conversion factors were derived from the 1W2H frequency ratio of water, 13C frequency of the methyl groups of internal DSS, the '5N frequency of external liquid ammonia, and the 31P frequency of internal trimethylphosphate, respectively (see reference 42 for details). It is recommended here that the relative frequencies (Table 3 ) be used as fried constants not subject to further change and that they be used for data collected at all temperatures (with no applied temperature correction) and with the primary reference as either internal TMS (4 or DSS (&) . It is anticipated that standardized Evalues for additional nuclei of interest to biomolecular spectroscopists will be developed and published as recommendations (ref. 41).
Resonance assignments
Resonance assignments constitute a prerequisite for the commonly used structure determination procedures.
Because the final quality of the structure depends to a large extent on the completeness of the underlying resonance assignments, their full description is important. Deposition of chemical shift assignments is imperative (see 10. below). Quantitative information on the completeness of assignments obtained, including a listing of the missing assignments, is of prime interest. If, as part of automated assignment procedures, parameters are available that provide a measure for the reliability of a particular assignment, it is desirable that such parameters be presented along with the assignments themselves.
Sequence-specific assignment of polypeptide chains
The assignment process for polypeptides consists of sequence-specific assignments of backbone and side chain resonances.
Sequential backbone assignment
In most cases, a brief description should suffice, since present assignment strategies employ one or both of the two following approaches.
Assignments derived from sequential NOEs and 'H-'H J-correlation. If samples with solution conditions
(e.g., pH, temperature, ionic strength) different from those reported in the assignment table were used in determining or validating assignments, this information needs to be noted. It is useful to report other information relevant to the assignment process, such as improvement of the spectral resolution by isotopic labeling, including 1H/2H exchange of amide groups. It is recommended that this include description of the types of J-correlation experiments used in the sequential assignment process.
Sequential assignments derived from homonuclear and heteronuclear J-correlations across peptide bonds.
Although uniform double labeling with 15N and 13C is most commonly employed with this approach, other labeling patterns may be used. If non-uniform labeling was employed, important information includes a description of the labeling strategy and a list of the labeled proteins used. In cases where NOEs were used in parallel to establish or validate assignments, this information is of interest.
Amino acid side-chain assignment
Side chain assignments, although conceptually simple, are often complicated by spectral overlap, strong coupling, and rapid transverse relaxation. Various isotope labeling strategies and NMR techniques have been devised to overcome these problems. Unless novel methods have been employed, it should suffice to reference the approaches used. It is recommended that the report contain a list of the experiments used, the fraction of the side chain resonances that have been correlated through J-couplings to the backbone, and the extent to which NOES have been used in the assignment or validation process.
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Sequence-specific assignment of nucleic acids
The assignment process for nucleic acids consists of two phases. In one part, the sugar-phosphate backbone resonances are assigned, together with the purine H8 and the pyrimidine H5 and H6 resonances. This assignment usually is based on combined use of NOEs, IH-lH J-correlation, and IH-3IP J-correlation, and, in cases where isotopic labeling is used, on 'H-13C, I3C-I3C, l3C-l5N, and 13C-3lP J-correlations. In the second part, the remaining base protons (adenine H2 and all exchange labile protons) are assigned, usually by NOE methods, but possibly also by isotopic labeling and J-correlation. For both parts, it is important to report how the resonance assignments were established and what assumptions regarding the conformation of the oligonucleotide were used in making assignments that involve NOEs. Further pertinent information includes temperature and solvent conditions and, if applicable, the level and pattern of isotopic enrichment.
Stereospecific assignment of diastereotopic substituents
It is useful to indicate in the assignment table which method was used to make each stereospecific assignment. Unless a novel approach was used, the description may consist of a brief reference to one of the methods in common use.
Analysis of J-couplings and short-range NOEs.
It is useful to report the J-couplings and the experiments used for their measurement along with any NOEs utilized in making the stereospecific assignments. If computational methods, such as systematic grid searches, were used, they should be referenced or described briefly.
Stereoassignment by isotopic labeling. It is customary to report how the labeling was achieved (e.g., isotopic composition of cell growth medium) and what the observed levels of enrichment were for the pertinent sites in the biomolecule.
Stereospecific assignments by reference to preliminary
structures. Indicate the software package and any statistical criteria (confidence level) employed.
Conformational equilibria
The criteria used to deduce the existence of multiple states (as may result, for example, from partial folding, oligomeric heterogeneity, cofactor or ligand binding heterogeneity, peptide bond cidtrans isomerization, or hairpin-duplex equilibrium) are of prime interest. A separate designator is supplied for each individual state and associated with its NMR parameters. Fractional occupancies and interconversion rates for the states (or bounds on these) may be included if known.
Conformational features derived from diagnostic NMR parameters
Polypeptide secondary structure
It is a special feature of protein structure determination by NMR that the secondary polypeptide structure, including the connections between individual segments of regular secondary structure, can be determined early on in connection with the resonance assignments, before the complete structure calculation is even started. Reports on such identification of regular secondary structures and tight turns will be of interest also in the foreseeable future, for example, as a preliminary structural characterization of a novel protein or in connection with studies on protein folding. The information used for secondary structure identification is concisely documented in a survey diagram of the type shown in Fig. 8 . The data in Fig. 8 include spin-spin coupling constants 3 J~~~m sequential NOEs d, , d", and dpN, i+3), d, p(i, i+3), d&i, i+4), d"(i, i+2) , and d&i,i+2) (ref. 47), and conformation-dependent chemical shifts for the a-carbons, d 6 ( I 3 C 9 . The diagram can be expanded readily for inclusion of additional parameters of diagnostic value for secondary structure determination. Figure 8 gives complete data for identification of helical structure (ref. 33) and N-caps in helices (ref. 49) . Although segments of extended chain also can be recognized from presentations of this type (Fig. 8) , additional information on long-range NOES is needed for the identification of /3-sheets. A two-dimensional drawing of the ,&sheets enables a concise presentation of these data, which may even include some details on the experiments used (Fig. 9) . 
Polynucleotides
Mononucleosides
The conformation of a mononucleoside within a nucleic acid structure is determined by the sugar conformation and the glycosidic torsion angle. Diagnostic characterization of these structural features often is possible from simple inspection of the NMR spectra.
In a ribose ring, 3 J H 1~2 t = 1 Hz is diagnostic for the N-puckered conformation ( P = 0" to 18"), and 3JHltH2/ = 7.9 Hz is diagnostic for the S-puckered conformation ( P = 144" to 162"). In a deoxyribose ring, 3JH1tH2~ = 1.8 Hz is diagnostic for the N-puckered conformation (P = 0" to 18"), and 3JH1'H2' = 10 Hz is diagnostic for the S-puckered conformation ( P = 144" to 162"). The distance between H6 (in pyrimidines) or H8 (in purines) and the sugar ring proton H1' varies from -2.5 A (0.25 nm) in the syn (x= 60") orientation to -3.7 A (0.37 nm) in the anti (x= 240") orientation. The anti orientation, which is found in A-and B-type helices, therefore, is characterized by cross-relaxation cross peaks of low intensity. The syn conformation, which is found, for example, in the G-residues in Z-DNA, is characterized by cross-relaxation cross peaks of high intensity. Pyrimidine residues are rarely found in the syn orientation. The distance between H6 (in pyrimidines) or H8 (in purines) and the sugar ring proton H2' varies from -2 A (0.2 nm) in the anti orientation to -4 A (0.4 nm) in the syn orientation. Because these distances are nearly independent of the sugar pucker, the magnitudes of their cross-relaxation cross peaks are particularly useful for estimating the magnitude of the glycosidic angle x.
Until a specifk format for the presentation of these diagnostic data has been agreed upon, description in the text is recommended.
Backbone angles
In favorable situations, heteronuclear 1H -3lP coupling constants can be used to recognize preferred backbone conformations. The preferred orientation of the backbone angle p ( P -0 5 ' 4 5 ' 4 4 ' ) in helixtype structures is in the trans range, which is characterized by relatively s m d values for 3JH5jp and 3JH5~~p (about 2 to 5 Hz). Unusual folding patterns (e.g., in loop structures) can lead to p values in the g+ range, characterized by 3JH57, = 24 Hz, or the g-range, characterized by 3JH5jp = 24 Hz. In B-type DNA helices, the torsion angles p and y are in the preferred pt and y + conformations, and the fragment P 4 5 ' 4 5 ' 4 4 ' -H 4 '
forms an all-trans, planar, W-type geometry. This results in a long-range 4JH4'p coupling constant of 2-3 Hz, which is large enough to lead to discernible lH -31P hetero-COSY cross peaks. In A-type RNA helices, p and yadopt similar preferred conformations, but the resulting geometry is not of the 'ideal', all-trans, planar, W-type, and thus no 1H -31P cross peaks are visible for the H4' -P combination. The backbone torsion angle E, which has the preferred orientation 6, is characterized by a similar effect: when E switches to the E -orientation ( E + is forbidden), the fragment H 2 ' 4 2 ' 4 3 ' -03' -P can form a planar, W-type geometry, which is characterized by the presence of lH2'-3lP hetero-COSY cross peaks. Until a specific format for the presentation of these data has been proposed, it is recommended that they be presented either in a table or as part of the text.
Secondary structure
The observation of imino proton resonances between 11.5 and 14.5 ppm is indicative of the presence of base-paired helical regions in a nucleic acid. The resonance intensity in this spectral range provides a lower limit to the number of helical base pairs. The occurrence of imino proton resonances at 6~~s > 14.5 ppm is indicative of the presence of protonated cytosine involved in base-pair hydrogen bonding.
Collection of input constraints and structure calculation
The collection of constraints used in calculating the structure of a protein or nucleic acid usually is an iterative process, where an initial fold, determined on the basis of a small number of constraints supports the identification of additional constraints, which supplement the original constraints in the next round of refinement. Thus, the collection of input constraints can be considered an integral part of the structure calculation process, and both aspects are dealt with in this section.
Conformational constraints
Distance constraints from NOE data
It is customary to describe the methods used to assign NOE cross peaks and those employed to convert NOE cross peak intensities into interproton distance constraints. It is essential that the procedure followed in determining the constraints be described in sufficient detail that a worker could repeat their derivation given equivalent NOE data. It is important to speclfl whether all types of protons were treated equally, or whether special corrections were made, for example, to account for motional averaging or interactions involving methyl groups. For oligomeric proteins, it is important to describe if and how intermolecular NOES were distinguished from intramolecular interactions.
Torsion angle constraints from J-coupling data
It is usual to specify the methods used to relate J-couplings to structural constraints. This includes the specific Karplus-type relationships employed, their representation by an energetic penalty function during the structure calculation (see for example, ref. 50) , and possibly additional criteria used to resolve the up to four-fold degeneracy of the Karplus relation between torsion angle and J-coupling.
Torsion angle constraints from chemical shifts
If chemical-shift-derived torsion angle constraints are used in the structure refinement procedure, it is important to describe the energetic penalty function used, the method by which the predicted shift was calculated, and the refinement stages in which chemical shift information was included. 
Constraints representing disulfide bonds, hydrogen bonding, and metal coordination
Supplementary constraints for structure refinement
Structural information may be derived from a variety of additional sources, including evidence of hydration, effects of paramagnetic shift and relaxation reagents, isotope shifts, nuclear quadrupole couplings, photochemical chemically induced dynamic nuclear polarization (photo CIDNP) experiments, field dependence of J-couplings, anisotropy of relaxation times, etc. It is important to describe in some detail the way in which these data were collected and the means by which they were applied to the structure calculation.
It is important to document all assumptions and additional sources of information used in calculating the structure from the experimental data.
If an energetic penalty function was used, its functional form should be specified.
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Input for the final structure calculation
Data bank deposition of the input for the final structure calculation is considered to be as important as the deposition of the final atomic coordinates (10. The number of torsion angle or J-coupling constraints used, classified by the type of angle (9, $v, xl, etc., in polypeptides; / I , S, E, x, the sugar pucker constraints, and, if used, the staggered conformations of the a and (angles in nucleic acids).
The number of hydrogen bond constraints (with a distinction made between the number of constrained hydrogen bonds and the number of constraints used to describe these bonds).
If applicable, other types of constraints. 
Methods used for structure calculation and refinement
The computational methods used for structure determination and refinement (including names and versions of software packages used) need to be specified in adequate detail, and it is important to provide references to parameter sets, potential functions and values of force constants used, or to include these values explicitly in the report if they have not been published elsewhere.
Structure calculation
It is desirable that the process for deriving the three-dimensional structure from the NMR data be described clearly, including the starting conformation(s), numbers and types of constraints used, and the criteria used to reject unfavorable folds. It is important to describe the protocol used in minimizing the energetic penalty function during the various stages of refinement (for example, the initial and final temperatures together with the number of steps, the step size, and the force constants used in simulated annealing protocols).
Preliminary structures to assign additional constraints
Currently, most structure determination protocols remove ambiguities from NOE cross-peak assignments by reference to an initial fold calculated with an incomplete set of (ideally unambiguous) constraints. It is important to document any ambiguity in the initial set of constraints along with the methods used for assigning additional constraints, for example, by reference to the software used and by reporting adequate details on the procedures (number of iterations, criteria and cut-off values) employed for the rejection of NOEs at various stages in the refinement.
Structure refinement
Structure refinement procedures which rely on computationally intensive programs for relaxation matrix refinement or chemical shift calculations are frequently only incorporated during the final stages of the structure determination. It is important to provide sufficient details regarding the use of these procedures, including their effects on the average structure used as input for the refinement, and their effect on the root-mean-square deviation of the ensemble of structures.
9.
Reporting three-dimensional structures
Presentation of structures
In reporting three-dimensional NMR structures it is common practice to display the entire ensemble of conformers used for statistical analysis. In addition, a representative conformer, suitable for detailed structural interpretation, often is presented. The representative conformer has been identified variously as the structure that best satisfies the NMR constraints, as the energy-minimized structure derived from the averaged coordinates of the ensemble, or as the structure that is closest to the averaged coordinates of the ensemble (ref. 53). Subtleties in the averaging of NMR properties (ref. 54), which differ from averaging in Xray crystallography, need to be considered. It is important to specify the total number of conformers calculated and the criteria for selection of the subset of conformers, including the representative conformer used for display and analysis.
Agreement of structures with constraints
0
It is important to report complete statistics as to how well the structures satisfy the constraints. The maximum violations of distance bounds, torsion angle constraints, coupling constants, chemical shifts, or other experimental constraints used in the structure calculation, are normally reported, together with the average violation per constraint (k standard deviation).
When computational methods are used that provide a measure of the agreement of the structures with the constraints or with direct spectroscopic data such as NOE intensities, the final value of the target function or figure of merit (R-factor) normally is reported. In the particular case of relaxation matrix calculation of NOE intensities, it is appropriate to specify the functional form of the R-factor (e.g., direct, i-6 weighted, etc.). It is usual to specify the deviations from idealized covalent geometry for bond lengths, bond angles, and impropers and to indicate which idealized geometry was used. Since covalent bond lengths and angles are restrained to "ideal" values in all methods currently used to compute NMR structures, deviations from ideality do not provide an independent assessment of the overall quality of the structures but can identify problem regions where constraints might be too tight or where constraints may be in conflict as a result of conformational averaging. 
Precision of structures
An ensemble of conformers calculated from the same set of input data is widely used to represent an NMR-derived structure. The precision of the structure determination commonly is expressed in terms of a statistical analysis of the variation of the atomic coordinates and torsion angles among these conformers. The precision may then be reported either as average pairwise root mean square (rms.) deviation or the rms. deviation relative to the mean coordinates. A meaningful description of the precision of local structure is provided by the circular variance (ref. 5 5 ) or the angular order parameter (ref. 56) for torsion angles. It is useful to specify the method of superposition used in obtaining the mean coordinates. For proteins, the average rms. deviation for Cartesian coordinates usually is reported for a set of backbone heavy atoms, i.e., sets of (Ca), (N, Ca, C), or (N, Ca, C, 0) atoms, all side-chain heavy atoms, and all heavy atoms (backbone plus side chain). It is important to indicate whether the reported rms. deviations apply to all amino acid residues or only to a selected subset. For nucleic acids, the atoms used for calculations of rms. deviations should be specified.
Useful supplementary information includes evaluation of the rms deviations along the sequence in light of the density of constraints per residue, in order to better evaluate the significance of the apparent precision.
Validation of structures
In common with other methods for three-dimensional structure analysis, for example X-ray diffraction in single crystals, there is no direct method for absolute validation of the result of an NMR structure determination. Nonetheless, a number of criteria are available for investigating whether the result of an NMR structure determination is "reasonable." Such approaches have been developed only recently and are being used to evaluate the results of both NMR and X-ray structure determinations. Additional techniques are currently in development in different laboratories. These commonly are based on the database of currentlyavailable three-dimensional structures (ref. 55-6 1) . Criteria used for structure validation include the following:
Conformational energy (either Lennard-Jones or total energy) with associated force field used.
For proteins, a Ramachandran (4, w) plot for the backbone torsion angles in the family of conformers.
For more detailed assessment of the stereochemical quality of a protein structure, several computer programs are available (reviewed in reference 60). These may identify regions of the structure in which potential problems require further evaluation. Most of these programs have been written primarily for checking X-ray coordinates, rather than an ensemble of conformers obtained by NMR, but a recently published suite of programs (ref. 61) has been designed for the validation of NMR structures.
Data bank deposition of NMR structures and supporting data
Deposition in public data banks of the quantitative and semi-quantitative data and references to specific procedures used to manipulate the data, as described in these recommendations, is strongly encouraged, even in cases where this duplicates information tabulated in journal articles. The key elements in a data deposition for an NMR structure include:
Representation of the covalent structure(s) of the molecule(s) in the system reported (generally a sequence plus indications of cross links and special modifications) plus information on bound cofactors or other ligands and oligomeric structure. Tabulation of assigned chemical shifts. Tabulation of assigned coupling constants. Tabulation of constraints used in the structure calculation: distance constraints from NOES (or the spectroscopic data from which the constraints were derived), torsion angle constraints from J-couplings and chemical shifts, H-bond constraints, disulfide bridge constraints, and supplementary constraints: it is important to indicate how the constraints were calibrated and the nature of any pseudoatom or other corrections (e.g., to account for spin diffusion or spin multiplicity) included in the constraint values and to specify what type of averaging protocol (e.g., center averaging, r6 averaging, etc.) has been used (ref. 54, 62) . Cartesian coordinates for the family of conformers that represent the result of the structure determination as well as for a single representative conformer: it is important to include all available atoms in the deposition, including the protons. Concise description of the solution conditions used for the structure determination (temperature, pH, ionic composition, etc.). Literature citations for the studies that originated the deposited data.
Compilers of databases are encouraged to accommodate the deposition of supplementary information of the kind described in the preceding sections either as free text or in a more organized format. This may include a brief description of the computational techniques (including specification of the software) used to process the input data, derive and refine the structures, and validate the results.
Additional information usefully available from a database includes tables of NMR relaxation rates, hydrogen exchange rates or protection factors, and thermodynamic parameters characterizing conformational equilibria and ligand binding. Some authors may wish to deposit electronic fdes containing the free induction decays from a representative cross-relaxation experiment and/or lists of peaks and intensities of the primary data sets.
In analogy with the reporting of structures determined by X-ray crystallography, it is desirable that journal editors require, as a condition for acceptance of a publication, database deposition of at least (1) the atomic coordinates, (2) the assigned chemical shifts, (3) the assigned J-couplings, and (4) a compilation of all input constraints used for the structure determination.
Conclusion
The recommendations presented here are designed to support easier communication of NMR data and NMR structures for proteins and nucleic acids through unified nomenclature and reporting standards. Much of this document pertains to the reporting of data in journal articles. However, in the best interest of the future development of structural biology, it is desirable that the bulk of the reported information be stored in computer-accessible form and be freely accessible to the scientific community. For such purpose, the macromolecular crystallographic community is advocating use of the m C I F format (ref. 63, 64) , which is compatible with the STAREIF format (ref. 65, 66) ; mmCIF has been implemented in the Nucleic Acid Database. In recognition of the desirability of developing full compatibility between machine-readable crystal diffraction and NMR data, it is recommended that a compatible format be used for NMR data from proteins and nucleic acids. It may prove desirable, in addition, for the databases to develop full compatibility with the ASN.l data exchange format (ref. 6 7 -6 9 ) , which has been adopted by the U.S. National Center for Biotechnology Information and is being used in the chemical exchange format developed by the Chemical Abstracts Service (ref. 70) . With these goals in mind, international committees, in association with the Protein Data Bank and BioMagResBank, are in the process of using the present document to develop data dictionaries and author-input protocols for the deposition of macromolecular NMR data (ref. 71).
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